pfezziwig Posted October 3, 2007 Report Posted October 3, 2007 After a promising Jan07 publication revealing DCA might fight cancer, Health Canada Ok'ld a Phase 2 study on some seriously ill cancer patients. DCA has highlighted the apparent need to fund research for drugs that are unprofitable. DCA is cheap and cannot be patented, therefore it's not a potentially profitable drug to fund research if you are a pharmaceutical company or a beauracratic lackey dolling out research dollars either. Dr. Michelakis appears to be laying the framework for other researchers to raise funding for other studies involving less profitable potential cures big pharmaceuticals won't fund. Which is almost as daunting a task as fighting cancer. They raised 800000 through personal donations ! Health Canada flexed some muscle and showed their independence from big pharmaceutical company control by approving a study to begin with and secondly for allowing a phase 2 level study rather than level 1, as they viewed it's long history as reassuring for its safety. Now if only the NRC and Breast Cancer organizations would only start funding drugs that don't make money... ---------------------- P.Fezziwig, contributor for Healthcare Reviews , http://www.healthcarereviews.com , building a better healthcare system through patient feedback. Quote Healthcare Reviews , rate your doctor, dentist, hospital and more
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.